Berkeley UC
From 2007.igem.org
JCAnderson (Talk | contribs) |
JCAnderson (Talk | contribs) |
||
| Line 70: | Line 70: | ||
<td class="tddesc"><b><a href="https://2007.igem.org/BerkiGEM2007Present4">The Chassis</a></b><p><i>Our bacterial | <td class="tddesc"><b><a href="https://2007.igem.org/BerkiGEM2007Present4">The Chassis</a></b><p><i>Our bacterial | ||
chassis has been heavily modified to remove its | chassis has been heavily modified to remove its | ||
| - | sepsis-inducing toxicity, | + | sepsis-inducing toxicity, immunogenic factors, and ability to grow |
| - | + | within the bloodstream, as well as promote its ability to last | |
| - | in the bloodstream by masking it from the immune | + | longer in the bloodstream by masking it from the immune |
system.</i></td> | system.</i></td> | ||
</tr> | </tr> | ||
| Line 79: | Line 79: | ||
<a href="https://2007.igem.org/BerkiGEM2007Present3"><img border="0" src="https://static.igem.org/mediawiki/2007/8/8d/Berk-Icon-Controller.png" width="121" height="121"></a></td> | <a href="https://2007.igem.org/BerkiGEM2007Present3"><img border="0" src="https://static.igem.org/mediawiki/2007/8/8d/Berk-Icon-Controller.png" width="121" height="121"></a></td> | ||
<td class="tddesc"><b><a href="https://2007.igem.org/BerkiGEM2007Present3">The Controller</a></b><p><i>The Controller | <td class="tddesc"><b><a href="https://2007.igem.org/BerkiGEM2007Present3">The Controller</a></b><p><i>The Controller | ||
| - | is an integrated genetic circuit | + | is an integrated genetic circuit comprised of two plasmids that allows |
| - | + | stable maintenance of the system's various operons on a large single-copy | |
| - | + | plasmid in a dormant state. Upon induction, the copy number of the | |
| - | + | operons and their transcription increase 100-fold resulting in a | |
| - | + | dramatic increase in protein expression.</i></td> | |
</tr> | </tr> | ||
<tr> | <tr> | ||
| Line 98: | Line 98: | ||
<td class="tdboxes"> | <td class="tdboxes"> | ||
<a href="https://2007.igem.org/BerkiGEM2007Present2"><img border="0" src="https://static.igem.org/mediawiki/2007/c/ce/Berk-Icon-Freeze-Drying.png" width="121" height="121"></a></td> | <a href="https://2007.igem.org/BerkiGEM2007Present2"><img border="0" src="https://static.igem.org/mediawiki/2007/c/ce/Berk-Icon-Freeze-Drying.png" width="121" height="121"></a></td> | ||
| - | <td class="tddesc"><b><a href="https://2007.igem.org/BerkiGEM2007Present2">Freeze Drying</a></b><p><i> | + | <td class="tddesc"><b><a href="https://2007.igem.org/BerkiGEM2007Present2">Freeze Drying</a></b><p><i>To |
enable preservation of our bacteria for long time periods, | enable preservation of our bacteria for long time periods, | ||
we are including the ability to produce the compounds | we are including the ability to produce the compounds | ||
| - | hydroxyectoine and trehalose | + | hydroxyectoine and trehalose that will enable our bacteria to |
survive freeze-drying intact. This will dramatically | survive freeze-drying intact. This will dramatically | ||
increase shelf-life and decrease transport costs.</i></td> | increase shelf-life and decrease transport costs.</i></td> | ||
Revision as of 15:04, 12 October 2007
| UC Berkeley iGEM 2007 |
The necessity of inexpensive, available, disease free, and
universally compatible blood substitutes is undisputed. There are
currently no blood substitutes approved for use in the US or the UK,
and whole blood is almost always in short supply. Developing
countries have the greatest need for blood transfusions, however
many lack the necessary donation and storage infrastructure and the
required number of healthy donors. To address this problem, we are
developing an innovative and cost-effective blood substitute
constructed from E. coli bacteria engineered to include the
critical capabilities of human erythrocytes. Our bacterial system
includes the ability to safely exist in the bloodstream, carry
oxygen with hemoglobin, and be stored for prolonged periods in a
freeze-dried state.
Support for Berkeley iGEM 2007 was generously provided by SynBERC and The Camille and Henry Dreyfus Foundation, Inc.
The System's Devices |
|
 |
Oxygen Carrying Our system is designed to produce Hemoglobin, Heme, and the necessary chaperones and detoxifying agents to promote the transport of oxygen throughout the bloodstream. We also investigated alternates to hemoglobin and other strategies for its production. |
 |
The Chassis Our bacterial chassis has been heavily modified to remove its sepsis-inducing toxicity, immunogenic factors, and ability to grow within the bloodstream, as well as promote its ability to last longer in the bloodstream by masking it from the immune system. |
 |
The Controller The Controller is an integrated genetic circuit comprised of two plasmids that allows stable maintenance of the system's various operons on a large single-copy plasmid in a dormant state. Upon induction, the copy number of the operons and their transcription increase 100-fold resulting in a dramatic increase in protein expression. |
 |
Genetic Self-Destruct To prevent chance of infection or unwanted proliferation after hemoglobin production, we have engineered a genetic self-destruct mechanism whereby when induced, the bacterial cell will express a genetic material-degrading toxin which kills the cell, but leaves it physically intact. |
 |
Freeze Drying To enable preservation of our bacteria for long time periods, we are including the ability to produce the compounds hydroxyectoine and trehalose that will enable our bacteria to survive freeze-drying intact. This will dramatically increase shelf-life and decrease transport costs. |
Team Members |
| Advisors John Dueber • Christopher Anderson • Adam Arkin • Jay Keasling Teaching Assistants Undergraduate Researchers High School Students |
|
Oligo List Spreadsheet
Biobricks and Cloning Tutorials
UC Berkeley iGEM 2006 OpenWetWare |
Team Notebooks
|
